IL152177A0 - Piperazine and piperidine compounds - Google Patents

Piperazine and piperidine compounds

Info

Publication number: IL152177A0
Authority: IL; Israel
Prior art keywords: piperazine; piperidine compounds; piperidine; compounds
Prior art date: 2000-05-12

Application number

IL15217701A

Other languages

English (en)

Original Assignee

Solvay Pharm Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-12

Filing date

2001-05-10

Publication date

2003-05-29

2001-05-10 Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv

2003-05-29 Publication of IL152177A0 publication Critical patent/IL152177A0/xx

Links

GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 2
150000003053 piperidines Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Addiction (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

IL15217701A 2000-05-12 2001-05-10 Piperazine and piperidine compounds IL152177A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00201699		2000-05-12
PCT/EP2001/005320 WO2001085725A1 (fr)	2000-05-12	2001-05-10	Composes de piperazine et piperidine

Publications (1)

Publication Number	Publication Date
IL152177A0 true IL152177A0 (en)	2003-05-29

Family

ID=8171488

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL15217701A IL152177A0 (en)	2000-05-12	2001-05-10	Piperazine and piperidine compounds
IL152177A IL152177A (en)	2000-05-12	2002-10-08	Piperazine and piperidine compounds,

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL152177A IL152177A (en)	2000-05-12	2002-10-08	Piperazine and piperidine compounds,

Country Status (27)

Country	Link
US (2)	US6911448B2 (fr)
EP (1)	EP1283838B1 (fr)
JP (1)	JP2003532729A (fr)
CN (1)	CN1174979C (fr)
AR (1)	AR028443A1 (fr)
AT (1)	ATE255578T1 (fr)
AU (2)	AU6392701A (fr)
BR (1)	BR0110592A (fr)
CA (1)	CA2405971C (fr)
CZ (1)	CZ301464B6 (fr)
DE (1)	DE60101386T2 (fr)
DK (1)	DK1283838T3 (fr)
DZ (1)	DZ3370A1 (fr)
ES (1)	ES2211809T3 (fr)
HU (1)	HUP0302016A2 (fr)
IL (2)	IL152177A0 (fr)
MX (1)	MXPA02011084A (fr)
NO (1)	NO323778B1 (fr)
NZ (1)	NZ522116A (fr)
PL (1)	PL198857B1 (fr)
PT (1)	PT1283838E (fr)
RU (1)	RU2261250C2 (fr)
SK (1)	SK286778B6 (fr)
TR (1)	TR200302294T4 (fr)
UA (1)	UA72337C2 (fr)
WO (1)	WO2001085725A1 (fr)
ZA (1)	ZA200208537B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6392701A (en) *	2000-05-12	2001-11-20	Solvay Pharm Bv	Piperazine and piperidine compounds
US7504395B2 (en) *	2001-07-20	2009-03-17	Psychogenics, Inc.	Treatment for attention-deficit hyperactivity disorder
WO2004000837A1 (fr) *	2002-06-25	2003-12-31	Sumitomo Pharmaceuticals Co., Ltd.	Nouveau derive de benzoxazolinone
ES2232292B1 (es) *	2003-07-30	2006-11-01	Laboratorios Del Dr. Esteve, S.A.	Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos.
US7596407B2 (en)	2004-03-26	2009-09-29	Solvay Pharmaceuticals, B.V.	Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
EP1595542A1 (fr) *	2004-03-26	2005-11-16	Solvay Pharmaceuticals B.V.	Administration iontophoretique de composés piperazinyl-2(3h)-benzoxazoloniques
AR058022A1 (es) *	2005-08-22	2008-01-23	Solvay Pharm Bv	Derivados de benzooxazoles, composiciones farmaceuticas y su uso para el tratamiento de desordenes del sistema nervioso.
JP2009504799A (ja) *	2005-08-22	2009-02-05	ソルベイ・フアーマシユーチカルズ・ベー・ブイ	ピペラジンおよびピペリジン誘導体のプロドラッグとしてのｎ−オキシド
US7750013B2 (en)	2005-08-22	2010-07-06	Solvay Pharmaceuticals, B.V.	N-oxides as prodrugs of piperazine and piperidine derivatives
US20070275977A1 (en) *	2006-05-02	2007-11-29	Van Aar Marcel P	N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US8106056B2 (en)	2006-06-16	2012-01-31	Solvay Pharmaceuticals B.V.	Combination preparations comprising bifeprunox and a dopamine agonist
CN101547923A (zh)	2006-12-07	2009-09-30	弗·哈夫曼-拉罗切有限公司	作为via受体拮抗剂的螺环-哌啶衍生物
JP2010511654A (ja)	2006-12-07	2010-04-15	エフ．ホフマン−ラロシュアーゲー	スピロ−ピペリジン誘導体
KR101050558B1 (ko)	2006-12-08	2011-07-19	에프. 호프만-라 로슈 아게	Ｖ1ａ 수용체 길항제로서 작용하는 인돌
MX2009005544A (es)	2006-12-08	2009-06-05	Hoffmann La Roche	Indoles.
CN101563324A (zh)	2006-12-22	2009-10-21	弗·哈夫曼-拉罗切有限公司	螺-哌啶衍生物
CN101918382A (zh) *	2008-01-15	2010-12-15	雅培卫生保健产品有限责任公司	联苯芦诺衍生物
CA3034895A1 (fr)	2016-08-26	2018-03-01	Exciva Ug (Haftungsbeschrankt)	Compositions et procedes associes
JP7186777B2 (ja) *	2018-07-27	2022-12-09	中国塗料株式会社	防汚塗料組成物、防汚塗膜、防汚塗膜付き基材及びその製造方法、並びに補修方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS60126275A (ja) *	1983-12-13	1985-07-05	Otsuka Pharmaceut Co Ltd	ベンゾチアゾ−ル誘導体
FR2567884B1 (fr) *	1984-07-19	1987-03-06	Roussel Uclaf	Nouveaux derives de l'indole, leur preparation, leur application comme medicaments et les compositions les renfermant
EP0185429A1 (fr)	1984-12-21	1986-06-25	Duphar International Research B.V	Pipérazines bicycliques
ATE81975T1 (de) *	1984-12-21	1992-11-15	Duphar Int Res	Arzneimittel mit psychotroper wirkung.
DE4127849A1 (de) *	1991-08-22	1993-02-25	Merck Patent Gmbh	Benzodioxanderivate
PT889889E (pt) *	1996-03-29	2007-01-31	Duphar Int Res	Composto de piperazina e piperidina
TW530054B (en) *	1997-09-24	2003-05-01	Duphar Int Res	New piperazine and piperidine compounds
GB9811879D0 (en) *	1998-06-03	1998-07-29	Knoll Ag	Therapeutic agents
UA71590C2 (en) *	1998-11-13	2004-12-15	Duphar Int Res	Piperazine and piperidine derivatives
AU6392701A (en) *	2000-05-12	2001-11-20	Solvay Pharm Bv	Piperazine and piperidine compounds
US20030186838A1 (en) *	2000-05-12	2003-10-02	Feenstra Roelof W.	Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders

2001
- 2001-05-10 AU AU6392701A patent/AU6392701A/xx active Pending
- 2001-05-10 US US10/257,677 patent/US6911448B2/en not_active Expired - Fee Related
- 2001-05-10 IL IL15217701A patent/IL152177A0/xx unknown
- 2001-05-10 MX MXPA02011084A patent/MXPA02011084A/es active IP Right Grant
- 2001-05-10 DZ DZ013370A patent/DZ3370A1/fr active
- 2001-05-10 BR BR0110592-2A patent/BR0110592A/pt not_active IP Right Cessation
- 2001-05-10 PT PT01938214T patent/PT1283838E/pt unknown
- 2001-05-10 AT AT01938214T patent/ATE255578T1/de active
- 2001-05-10 DE DE60101386T patent/DE60101386T2/de not_active Expired - Lifetime
- 2001-05-10 ES ES01938214T patent/ES2211809T3/es not_active Expired - Lifetime
- 2001-05-10 EP EP01938214A patent/EP1283838B1/fr not_active Expired - Lifetime
- 2001-05-10 SK SK1587-2002A patent/SK286778B6/sk not_active IP Right Cessation
- 2001-05-10 DK DK01938214T patent/DK1283838T3/da active
- 2001-05-10 CA CA2405971A patent/CA2405971C/fr not_active Expired - Fee Related
- 2001-05-10 TR TR2003/02294T patent/TR200302294T4/xx unknown
- 2001-05-10 RU RU2002133458/04A patent/RU2261250C2/ru not_active IP Right Cessation
- 2001-05-10 WO PCT/EP2001/005320 patent/WO2001085725A1/fr not_active Ceased
- 2001-05-10 CZ CZ20023721A patent/CZ301464B6/cs not_active IP Right Cessation
- 2001-05-10 PL PL358201A patent/PL198857B1/pl not_active IP Right Cessation
- 2001-05-10 CN CNB018093302A patent/CN1174979C/zh not_active Expired - Fee Related
- 2001-05-10 AU AU2001263927A patent/AU2001263927B2/en not_active Ceased
- 2001-05-10 NZ NZ522116A patent/NZ522116A/en not_active IP Right Cessation
- 2001-05-10 JP JP2001582326A patent/JP2003532729A/ja not_active Ceased
- 2001-05-10 HU HU0302016A patent/HUP0302016A2/hu unknown
- 2001-05-11 AR ARP010102239A patent/AR028443A1/es active IP Right Grant
- 2001-10-05 UA UA2002129990A patent/UA72337C2/uk unknown
2002
- 2002-10-08 IL IL152177A patent/IL152177A/en not_active IP Right Cessation
- 2002-10-22 ZA ZA200208537A patent/ZA200208537B/en unknown
- 2002-11-08 NO NO20025365A patent/NO323778B1/no not_active IP Right Cessation
2005
- 2005-05-16 US US11/129,465 patent/US7297699B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US20060089366A1 (en)	2006-04-27
JP2003532729A (ja)	2003-11-05
CA2405971A1 (fr)	2001-11-15
US6911448B2 (en)	2005-06-28
TR200302294T4 (tr)	2004-02-23
AU6392701A (en)	2001-11-20
PL198857B1 (pl)	2008-07-31
DZ3370A1 (fr)	2001-11-15
CA2405971C (fr)	2010-03-30
WO2001085725A1 (fr)	2001-11-15
PL358201A1 (en)	2004-08-09
SK286778B6 (sk)	2009-05-07
SK15872002A3 (sk)	2003-04-01
US7297699B2 (en)	2007-11-20
MXPA02011084A (es)	2003-03-10
AR028443A1 (es)	2003-05-07
ATE255578T1 (de)	2003-12-15
HUP0302016A2 (hu)	2003-09-29
HK1055952A1 (en)	2004-01-30
CN1429226A (zh)	2003-07-09
NZ522116A (en)	2004-04-30
CZ301464B6 (cs)	2010-03-10
BR0110592A (pt)	2003-04-01
PT1283838E (pt)	2004-04-30
ZA200208537B (en)	2004-01-22
UA72337C2 (uk)	2005-02-15
AU2001263927B2 (en)	2004-09-30
NO323778B1 (no)	2007-07-02
ES2211809T3 (es)	2004-07-16
IL152177A (en)	2009-08-03
EP1283838B1 (fr)	2003-12-03
EP1283838A1 (fr)	2003-02-19
RU2261250C2 (ru)	2005-09-27
DK1283838T3 (da)	2004-03-22
DE60101386D1 (de)	2004-01-15
DE60101386T2 (de)	2004-05-27
US20030119849A1 (en)	2003-06-26
NO20025365D0 (no)	2002-11-08
CN1174979C (zh)	2004-11-10
NO20025365L (no)	2002-11-08
CZ20023721A3 (cs)	2003-02-12

Publication	Publication Date	Title
AU2962602A (en)	2002-06-24	Piperazine derivatives
AU8395501A (en)	2002-02-13	Piperazine derivatives
IL151923A0 (en)	2003-04-10	Novel piperazine derivatives
IL153718A0 (en)	2003-07-06	Tetrahydropyridino or piperidino heterocyclic derivatives
IL148964A0 (en)	2002-11-10	Piperazine compounds
NO20023787D0 (no)	2002-08-09	Piperazin- og piperidinderivater
IL143028A0 (en)	2002-04-21	New piperazine and piperidine compounds
AU6392701A (en)	2001-11-20	Piperazine and piperidine compounds
PL369076A1 (en)	2005-04-18	Piperazine derivative
EP1313477A4 (fr)	2004-03-03	Composes et procedes
PL355654A1 (en)	2004-05-04	Piperidine and piperazine derivatives which function as 5-ht2a
EP1274424A4 (fr)	2003-09-17	Composes et procedes
GB0106177D0 (en)	2001-05-02	Piperazine derivatives
IL126295A0 (en)	1999-05-09	New piperazine and piperidine compounds
AU3862301A (en)	2001-09-03	Substituted piperazine compounds
GB0128984D0 (en)	2002-01-23	Packer
PL353590A1 (en)	2003-12-01	Piperidine alcohols
EP1343796A4 (fr)	2005-01-12	Composes et procedes
GB0009479D0 (en)	2000-06-07	Antihistaminic compounds
GB0019705D0 (en)	2000-09-27	Factor
PT1131308E (pt)	2004-10-29	Novos compostos de piperazina e piperidina
AU2002224105A1 (en)	2002-06-03	Piperidine compounds and medicinal use thereof
CA89153S (en)	2000-03-31	Headboard
GB9904614D0 (en)	1999-04-21	Piperidines
AU142209S (en)	2000-11-07	Jamb